Cometriq, also known as cabozantinib, is a medication used in the treatment of certain types of cancer, specifically advanced medullary thyroid cancer and advanced renal cell carcinoma. This drug belongs to a class of medications called tyrosine kinase inhibitors, which work by blocking the action of abnormal proteins that promote the growth of cancer cells.

Cometriq is typically prescribed for patients who have already undergone surgery to remove their cancer but have experienced a recurrence or spread of the disease. It is important to note that this medication is not a cure for cancer, but rather a treatment option that can help slow down the progression of the disease and improve quality of life.

As with any medication, Cometriq can cause side effects. Common side effects may include diarrhea, fatigue, nausea, decreased appetite, and high blood pressure. It is important to discuss any side effects with your healthcare provider, as they may be able to provide recommendations to help manage them.

Before starting treatment with Cometriq, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help ensure that Cometriq is safe and appropriate for you.

Overall, Cometriq can be an effective treatment option for patients with advanced medullary thyroid cancer and advanced renal cell carcinoma. It is important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to monitor your progress while taking this medication. If you have any questions or concerns about Cometriq, do not hesitate to reach out to your healthcare provider for guidance.